Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
These Are the Journalists Israel Has Killed Since the Start of the Iran War - 2Google's proposed data center in orbit will face issues with space debris in an already crowded orbit
- 3Grasping the Qualifications Among Separation and Dissolution
- 4Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- 5How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Ringleader of suspected human trafficking network arrested in Ethiopia
- Discussion on deployment of foreign troops ongoing, two sources tell 'Post'
- Authentic Urban areas: Rich Legacy and Lively Societies
- Flu cases are rising with a strain that makes older people sicker
- Spanish woman, 25, dies by legal euthanasia in case that drew national spotlight
- Best Amusement Park in Asia: Which One Is a Must-Visit
- 2026 will be the year NASA astronauts fly around the moon again — if all goes to plan
- How do my eyes adjust to the dark and how long does it take?
- Evidence of lost baptismal rite stage uncovered in Byzantine era cathedral near Sea of Galilee
